180 Life Sciences (ATNF), a NASDAQ-listed biotech firm, is set to issue $156 million in senior secured convertible bonds to institutional investors. According to a PR Newswire report, the company intends to use the raised capital to purchase additional Ethereum (ETH). This strategic move signals a significant foray into the cryptocurrency space by 180 Life Sciences. While the specific reasoning behind the ETH purchase hasn't been explicitly stated, it suggests the company sees potential in digital assets. Convertible bonds offer investors the option to convert their debt into equity, potentially benefitting from 180 Life Sciences' future growth. The purchase could be an investment, a strategic reserve, or potentially tied to future blockchain-related projects. Further details are expected to be released as the transaction progresses. ```

#ETH